Ad
related to: depo-provera side effect angergoodrx.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
DMPA, under brand names such as Depo-Provera and Depo-SubQ Provera 104, is used in hormonal birth control as a long-lasting progestogen-only injectable contraceptive to prevent pregnancy in women. [ 38 ] [ 39 ] It is given by intramuscular or subcutaneous injection and forms a long-lasting depot , from which it is slowly released over a period ...
Depot MPA (DMPA) and EC/MPA were developed by Upjohn in the 1960s. [12] [13] DMPA (brand name Depo-Provera) was introduced for use as a progestogen-only injectable contraceptive for the first time outside of the United States in 1969 and was subsequently approved for use in birth control in the United States in 1992.
Medroxyprogesterone acetate (brand names Depo-Provera, Provera, Depo-subQ Provera 104) [4] – 150 mg (intramuscularly) or 104 mg (subcutaneously) every 3 months [3] Norethisterone enanthate (brand names NET EN, Noristerat, Norigest, Doryxas) [ 5 ] – 200 mg (intramuscularly) every 2 months [ 3 ]
[1] [46] Other side effects of progestogens may include an increased risk of breast cancer, cardiovascular disease, and blood clots, among others. [2] Some of the side effects of progestogens are due not to their progestogenic activity but rather due to off-target activities (e.g., androgenic activity, glucocorticoid activity ...
Different forms of birth control have different potential side effects. Not all, or even most, users will experience side effects from a method. The less effective the method, the greater the risk of pregnancy, and the side effects associated with pregnancy. Minimal or no side effects occur with coitus interruptus, fertility awareness-based ...
Other side effects include breast tenderness/pain, headache, and libido changes. [26] Some fluid retention can occur, but weight gain is minimal. [26] Local injection site reactions have also been reported in 15 to 35% of women. [26] Effects of CICs on coagulation and fibrinolysis are minimal and are not thought to be clinically relevant. [27]
Contraceptive Technology reports a typical failure rate of 3% per year for the injection Depo-Provera, and 8% per year for most other user-dependent hormonal methods. [10] While no large studies have been done, it is hoped that newer methods which require less frequent action (such as the patch) will result in higher user compliance and ...
Depot medroxyprogesterone acetate, a birth control medication marketed under the brand name Depo-Provera; 2,2-Dimethoxy-2-phenylacetophenone, a radical initiator; N,N′-Dimethyl-1,3-propanediamine, a cross linking reagent; Dimethylol propionic acid; Des Moines Performing Arts, the organization that operates the Civic Center of Greater Des Moines
Ad
related to: depo-provera side effect angergoodrx.com has been visited by 100K+ users in the past month